生命科学资讯
生物技术与制药领域的最新动态
In the clinic for Feb. 12, 2026
Other news to note for Feb. 12, 2026
Regulatory actions for Feb. 12, 2026
Abbvie claims CMS’ selection of Botox violates the IRA
肿瘤、免疫和神经细胞参与癌症恶病质过程
Tumor, immune and neural cells are involved in cancer cachexia
Bridgebio公司软骨发育不全症III期试验成功
Achondroplasia phase III succeeds for Bridgebio
宇瀚专利新型TREM2激动剂
Yuhan patents new TREM2 agonists
2026年2月12日其他值得关注的新闻
Other news to note for Feb. 12, 2026
2026年2月11日融资动态
Financings for Feb. 11, 2026
2026年2月11日门诊
In the clinic for Feb. 11, 2026
2026年2月11日其他值得关注的新闻
Other news to note for Feb. 11, 2026
Madrigal以44亿美元Ribo交易将siRNA方法加入MASH产品线。
Madrigal adds siRNA approach to MASH pipeline in $4.4B Ribo deal
因安全与无效性,NIH终止Xarelto中风试验分支。
NIH ends Xarelto arm of stroke trial due to safety, futility
靶向胆固醇沉积或可治疗淋巴水肿
Targeting cholesterol deposition could treat lymphedema
Moderna因流感疫苗RTF信函股价下跌
Moderna dips on flu vaccine RTF letter
昆山新韵达生物科技合成新型抗体偶联药物
Kunshan Xinyunda Biotechnology synthesizes new ADCs
Aquinnah制药公司获得MAPT聚集抑制剂专利。
Aquinnah Pharmaceuticals patents MAPT aggregation inhibitors
Tempest Therapeutics公布收购CAR T资产计划
Tempest Therapeutics outlines plans for acquired CAR T assets
SUDO-550在多发性硬化症模型中展现强劲疗效
SUDO-550 demonstrates robust efficacy in MS models